Successful Bridging to Rituximab With Plasma Exchange in a Pediatric Patient With Severe Lupus Nephritis

Key Points

• Successful plasma exchange improved biomarkers in severe lupus nephritis.
• After treatment, a notable reduction in proteinuria was observed within two weeks.
• Case study detailing the treatment's efficacy in one pediatric patient with severe symptoms.
• Highlights innovative treatment options, suggesting plasma exchange may enhance rituximab effectiveness.